New drug aims to stop dangerous gut infection from returning
Prevention
Recruiting now
This study tests an experimental drug called LMN-201 to see if it can prevent C. difficile infection from coming back after standard antibiotic treatment. About 375 adults with a recent C. diff infection will receive either LMN-201 or a placebo. The main goal is to see if more pe…
Phase: PHASE2, PHASE3 • Sponsor: Lumen Bioscience, Inc. • Aim: Prevention
Last updated Jun 27, 2026 09:04 UTC